Compare Suncor Energy Inc. (SU) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Suncor Energy Inc. vs 10X Genomics Inc — how do they compare? Suncor Energy Inc. trades at $72.33 (market cap $82.76B), while 10X Genomics Inc trades at $82.23 (market cap $10.07B). The key difference: Suncor Energy Inc. is far larger — about 8.2× 10X Genomics Inc's market cap, and Suncor Energy Inc. pays a 2.39% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Suncor Energy Inc. for 57 Days and 10X Genomics Inc for 92 Days on average.
| SU | TXG | |
|---|---|---|
Market Cap | $82.76B | $10.07B |
Volume | 3,832,959 | 5,657,286 |
Sector | Energy | Health |
52-Week High | $71.87 | $97.74 |
52-Week Low | $38.17 | $11.48 |
Typical Hold Time | 57 Days | 92 Days |
Enterprise Value | $89.29B | $9.59B |
Dividend Yield | 2.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Suncor Energy (SU) trades at $72.17, up 5.91% in the past 24 hours and near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, though the RSI suggests mild overbought conditions. Fundamentally, the company maintains solid profitability with a 14.7% net income margin and a reasonable P/E of 13.46. Recent news highlights asset divestments and a CEO transition, while analyst consensus is strongly positive with 74% buy ratings.
The outlook for SU is favorable, supported by robust cash flow, aggressive shareholder returns, and a discounted valuation relative to peers. Key opportunities include global refining strength and debt reduction, while risks involve commodity price volatility and operational challenges. The stock's momentum and fundamental health suggest potential for continued upside, contingent on stable energy markets and execution of strategic initiatives.
TXG trades at $76.10, down 5.65% on the day, reflecting a bearish technical trend. The company reported revenue of $642.82M for 2025 with a net loss of $43.54M, though it has consistently beaten quarterly EPS estimates. Recent news highlights strong demand for its Atera spatial biology platform and a patent victory. The stock faces resistance near $77 and support at $72.
The outlook is mixed; strong product demand and improving margins offer upside, but persistent losses and high valuation ratios pose risks. Analyst consensus is divided, with a $74.30 price target slightly below the current price, indicating cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
